12 health care stocks move in Monday's after-market session
Winners Shares of Conformis CFMS rose 13.2% to $0.29 in Monday's after-market session. The company's market cap is $53.5 million. OKYO Pharma OKYO stock rose 13.08% to $2.68. Trading volume for this stock closed at 111.8K, which is 101.1% of its average full-day volume over the past 100 days. The market value of their outstanding shares is $58.3 million. Shares of Aytu BioPharma AYTU rose 11.96% to $0.57. The market value of their outstanding shares is $21.9 million. Cabaletta Bio CABA stock rose 11.3% to $1.28. The market value of their outstanding shares is $37.0 million. AN2 Therapeutics ANTX stock rose 10.64% to $8.42. The company's market cap is $163.3 million. AdaptHealth AHCO stock rose 9.86% to $24.5. The company's market cap is $3.2 billion. losers Enhabit EHAB stock fell 20.0% to $14.38 in Monday's aftermarket session. The market value of their outstanding shares is $717.5 million. According to the press release, second quarter results were released today. Hyperfine HYPR shares fell 6.21% to $1.21. The market value of their outstanding shares is $85.1 million. Stealth BioTherapeutics MITO stock fell 5.35% to $0.27. This stock traded at a volume of 1.0 million shares approaching, representing 41.6% of its average volume over the past 100 days. The company's market cap is $20.1 million. Shares of TransMedics Group TMDX fell 5.01% to $39.5. The company's market cap is $1.1 billion. According to the news, the second quarter earnings report is out today. Dermata Therapeutics' DRMA stock fell 5.0% to $0.55. The company's market cap is $5.0 million. Macrogenics MGNX stock fell 4.81% to $2.97. The market value of their outstanding shares is $182.1 million. See also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
![12 health care stocks move in Monday's after-market session](https://cdn.benzinga.com/files/imagecache/600x400xUP/images/story/2022/movers_image_13814.jpeg?#)
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
What's Your Reaction?
![like](https://vidianews.com/assets/img/reactions/like.png)
![dislike](https://vidianews.com/assets/img/reactions/dislike.png)
![love](https://vidianews.com/assets/img/reactions/love.png)
![funny](https://vidianews.com/assets/img/reactions/funny.png)
![angry](https://vidianews.com/assets/img/reactions/angry.png)
![sad](https://vidianews.com/assets/img/reactions/sad.png)
![wow](https://vidianews.com/assets/img/reactions/wow.png)